本文選題：平逆止喘 + 針刺治療��； 參考：《福建中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:評(píng)價(jià)平逆止喘方針刺治療慢性阻塞性肺疾病急性加重期的臨床療效以及對(duì)患者肺功能的影響。方法:收集2016年在廈門市中醫(yī)院呼吸科、針灸科門診及病房接受治療的慢性阻塞性肺疾病急性加重期患者(40歲-70歲),擬納入66例,根據(jù)隨機(jī)對(duì)照原則分為治療組、對(duì)照組各33例。對(duì)照組予西醫(yī)常規(guī)治療;治療組在西醫(yī)常規(guī)治療的基礎(chǔ)上予加針刺治療,取穴為膻中、中脘、大陵、肺俞、風(fēng)池、支溝、風(fēng)門,除膻中、中脘外,其它穴位均為雙側(cè)取穴,每日1次,14天為一個(gè)療程。治療組與對(duì)照組于治療前、治療后分別進(jìn)行mMRC、肺功能、癥狀體征的評(píng)分觀察,使用統(tǒng)計(jì)軟件SPSS20.0forwindows進(jìn)行數(shù)據(jù)統(tǒng)計(jì)學(xué)分析。結(jié)果:1、中醫(yī)癥候及療效分析方面:①治療組經(jīng)平逆止喘方針刺治療后總有效率為83.87%,對(duì)照組總有效率為76.67%,兩組比較具有統(tǒng)計(jì)學(xué)差異(P0.05),說明西藥的基礎(chǔ)上配合針刺治療時(shí),療效更佳;②2組均能較好的改善患者咳嗽、咳痰、喘息、氣短等癥狀(P0.05),且治療組的改善程度優(yōu)于對(duì)照組;③治療組在中醫(yī)癥候積分方面優(yōu)于對(duì)照組。2、肺功能方面:兩組治療后FEV1/預(yù)%與FEV1/FVC與治療前相比,差異有統(tǒng)計(jì)學(xué)意義(P＜0.01),說明治療后2組肺功能均有改善;而兩組治療后FEV1/預(yù)%與FEV1/FVC相比,差異無統(tǒng)計(jì)學(xué)意義(P0.05),說明兩組組療效相當(dāng)。3、mMRC評(píng)分方面:兩組治療后與治療前相比,具有顯著性統(tǒng)計(jì)學(xué)意義(P0.01);與對(duì)照組相比,治療組治療后呼吸困難改善程度比對(duì)照組明顯,差異有統(tǒng)計(jì)學(xué)意義(P＜0.05)。研究表明,平逆止喘方針刺治療慢性阻塞性肺疾病急性加重期有一定的療效。結(jié)論:平逆止喘方針刺治療慢性阻塞性肺疾病急性加重期具有明顯療效,可以改善患者臨床癥狀,提高患者生活質(zhì)量,是一種安全有效的治療方法。
[Abstract]:Objective: To evaluate the clinical effect of acupuncture on the treatment of acute exacerbation of chronic obstructive pulmonary disease and the effect on the pulmonary function of patients with chronic obstructive pulmonary disease. Methods: to collect 66 cases of acute exacerbation of chronic obstructive pulmonary disease (40 years old -70 years old), which were treated in the Department of respiration of Xiamen Chinese medicine hospital in 2016, in the clinic and ward of acupuncture and moxibustion department. The control group was divided into the treatment group, 33 cases in the control group. The control group was given conventional treatment with western medicine; the treatment group was treated with acupuncture on the basis of conventional treatment of Western medicine. The treatment group was taken as a combination of Shan Zhong, Zhong Wan, daling, lung Yu, wind pool, branch ditch, and wind gate. The other points were both bilateral acupoints, 1 times a day, and 14 days as a course of treatment. The control group before the treatment, after the treatment of mMRC, lung function, symptoms and signs of score observation, using statistical software SPSS20.0forwindows for statistical analysis. Results: 1, TCM syndrome and effect analysis: (1) the total effective rate after acupuncture treatment in the treatment group was 83.87%, the total effective rate of the control group was 76.67%, two groups. Compared with the statistical difference (P0.05), the effect of Western Medicine on the basis of acupuncture treatment is better, and the 2 groups can better improve the patient's cough, expectoration, wheezing, short breath and other symptoms (P0.05), and the improvement of the treatment group is better than the control group; (3) the treatment group is better than the control group.2 in the TCM syndrome score, the lung function: two groups of treatment. The difference was statistically significant (P < 0.01) compared with FEV1/FVC before treatment (P < 0.01), indicating that the lung function of the 2 groups was improved after treatment, but the difference between the two groups after treatment was not statistically significant compared with FEV1/FVC (P0.05), indicating that the curative effect of the two groups was equivalent to.3 and mMRC score aspects: the two groups were significantly different after treatment than before the treatment. Study significance (P0.01); compared with the control group, the improved degree of dyspnea in the treatment group was significantly higher than that of the control group. The difference was statistically significant (P < 0.05). The study showed that the acupuncture treatment for chronic obstructive pulmonary disease had a certain effect in the treatment of acute exacerbation of chronic obstructive pulmonary disease. The exacerbation period has obvious curative effect. It can improve the clinical symptoms and improve the quality of life of patients. It is a safe and effective treatment.

【學(xué)位授予單位】：福建中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R246.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 郭錦橋;王付德;陳金鵬;;保元平喘湯聯(lián)合平喘調(diào)中針刺法對(duì)無創(chuàng)通氣治療慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭的改善作用[J];河北中醫(yī);2016年11期

2 王東浪;;針?biāo)幗Y(jié)合治療AECOPD痰熱壅肺證128例分析[J];深圳中西醫(yī)結(jié)合雜志;2016年21期

3 韓美玲;陳紹平;賈欽堯;毛建;李果;李剛;;慢性阻塞性肺疾病患者外周血單個(gè)核細(xì)胞TREM-1mRNA的表達(dá)[J];中國臨床研究;2016年10期

4 劉慧;;針刺聯(lián)合穴位貼敷對(duì)慢性阻塞性肺病急性加重期患者中醫(yī)證候、生活質(zhì)量以及肺功能的影響[J];針刺研究;2016年03期

5 李艷麗;李軍利;孟鵬飛;;針刺聯(lián)合縮唇呼吸治療慢性阻塞性肺疾病急性加重期84例臨床觀察[J];中醫(yī)臨床研究;2016年14期

6 張玉梅;何柳;覃少佳;韋慶新;韋盛鍇;卓碧;;針灸對(duì)慢性阻塞性肺疾病急性發(fā)作期患者肺功能的影響[J];新中醫(yī);2016年05期

7 張文波;陳小菊;冷長燕;向小均;;巨噬細(xì)胞刺激蛋白在慢性阻塞性肺疾病患者中的表達(dá)及意義[J];中國呼吸與危重監(jiān)護(hù)雜志;2016年02期

8 金延強(qiáng);張偉;;從肝肺相關(guān)論治胸悶變異性哮喘[J];成都中醫(yī)藥大學(xué)學(xué)報(bào);2015年03期

9 謝民棟;梁劍凌;朱霞;;健脾益肺法治療脾肺氣虛型慢性阻塞性肺疾病急性加重期療效觀察[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2015年19期

10 黃水華;張瑛;張玉玲;;溫補(bǔ)肺腎定喘法對(duì)慢性阻塞性肺疾病急性加重期患者的療效及肺功能影響[J];中醫(yī)藥導(dǎo)報(bào);2015年12期

相關(guān)碩士學(xué)位論文 前2條

1 劉曉雪;針?biāo)幉⒅螌?duì)慢性阻塞性肺疾病急性加重期患者肺功能的臨床研究[D];福建中醫(yī)學(xué)院;2009年

2 陳霖;“肝腎同源”與情志調(diào)控機(jī)制的理論探討[D];廣州中醫(yī)藥大學(xué);2008年

，

本文編號(hào)：1843058